Related Experiment Videos

Heart transplantation in children with congenital heart disease

D T Hsu1, J M Quaegebeur, R E Michler

  • 1Department of Pediatrics, College of Physicians and Surgeons, Columbia University, Babies Hospital, New York, New York 10032, USA.

Insights

Pediatric heart transplantation for congenital heart disease shows similar survival rates to other cardiac conditions. However, children with congenital heart disease experienced longer surgery and more infections, requiring careful management.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Transplantation Medicine

Background:

  • Congenital heart disease (CHD) historically shows lower survival post-heart transplantation compared to cardiomyopathy.
  • Transplantation is increasingly considered for complex CHD, necessitating updated outcome data.
  • Previous reports suggest poorer outcomes for CHD patients, warranting reassessment of current results.

Purpose of the Study:

  • To describe heart transplantation outcomes in pediatric patients with congenital heart disease.
  • To compare these outcomes with pediatric patients undergoing heart transplantation for other cardiac conditions.

Main Methods:

  • Characterized diagnoses, prior surgeries, and indications for transplantation in CHD patients.
  • Compared pre-transplant course, graft ischemia time, survival, rejection, infection rates, and hospital stay.
  • Utilized a control group of 47 children transplanted for non-CHD reasons.

Main Results:

  • Thirty-seven children with CHD underwent transplantation; 86% had prior operations.
  • No significant differences in 1- and 5-year survival rates or rejection frequency were observed between CHD and non-CHD groups.
  • Patients with CHD had longer cardiopulmonary bypass and donor ischemia times, and a higher incidence of serious infections (p=0.01).

Conclusions:

  • Heart transplantation in children with complex CHD is feasible and achieves success rates comparable to other pediatric cardiac diseases.
  • Despite challenges like complex surgery and longer ischemia times, outcomes are similar.
  • Increased infection rates in CHD patients require vigilant post-transplant monitoring and management.
Abstract

Related Concept Videos